A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments.

Diabetes is an increasingly common metabolic disorder with high comorbidity and societal and personal costs. Insulin replacement therapy is limited by a lack of oral bioavailability. Recent studies suggest vanadium has therapeutic potential. A newly synthesized complex between oxidovanadium (IV) and...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 12
Autores principales: Naglah, Ahmed M., Al-Omar, Mohamed A., Almehizia, Abdulrahman A., Bhat, Mashooq A., Afifi, Walid M., Al-Wasidi, Asma S., Al-Humaidi, Jehan Y., Refat, Moamen S.
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 12/23/2018
Acceso en línea:Ver este registro en EBSCOhost